Definition
Primary effusion lymphoma (PEL) is a rare non-Hodgkin’s lymphoma that characteristically presents as a malignant effusion in the body cavities of patients with AIDS and occasionally in other patients with an underlying immunodeficiency. The malignant PEL cells are infected with Kaposi’s sarcoma-associated herpesvirus (KSHV, also known as human herpesvirus-8, HHV8) and are often coinfected with Epstein-Barr virus (EBV). PEL cells display morphologic features of large-cell lymphomas and are of B-cell lineage. The diagnosis of PEL is characteristically made in AIDS patients presenting with a malignant effusion in the pleural, pericardial, or peritoneal cavity characterized by the presence of KSHV-infected cells with characteristic morphology and phenotype. The clinical course of PEL is generally aggressive, with a mean survival of less than 1 year, despite chemotherapy.
Introduction
PEL was recognized as a distinct clinical entity when it was discovered that certain...
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
An J, Sun Y, Fisher M, Rettig MB. Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas. Leukemia. 2004;18:1699–704.
Aoki Y, Feldman GM, Tosato G. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood. 2003;101:1535–42.
Bubman D, Guasparri I, Cesarman E. Deregulation of c-Myc in primary effusion lymphoma by Kaposi’s sarcoma herpesvirus latency-associated nuclear antigen. Oncogene. 2007;26:4979–86.
Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332:1186–91.
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266:1865–9.
Gasperini P, Tosato G. Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma. Leukemia. 2009;23:1867–74.
Guasparri I, Keller SA, Cesarman E. KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med. 2004;199:993–1003.
Jones KD, Aoki Y, Chang Y, Moore PS, Yarchoan R, Tosato G. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi’s sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood. 1999;94:2871–9.
Luppi M, Trovato R, Barozzi P, Vallisa D, Rossi G, Re A, et al. Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir. Leukemia. 2005;19:473–6.
Menon MP, Pittaluga S, Jaffe ES. The histological and biological spectrum of diffuse large B-cell lymphoma in the world health organization classification. Cancer J. 2012;18:411–20.
Riva G, Luppi M, Barozzi P, Forghieri F, Potenza L. How I treat HHV8/KSHV-related diseases in post-transplant patients. Blood. 2012;11.
Sakakibara S, Tosato G. Viral interleukin-6: role in Kaposi’s sarcoma-associated herpesvirus: associated malignancies. J Interferon Cytokine Res. 2011;31:791–801.
Sarek G, Ma L, Enback J, Jarviluoma A, Moreau P, Haas J, et al. Kaposi’s sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas. Oncogene. 2012;2.
Speck SH, Ganem D. Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe. 2010;8:100–15.
Yarchoan R, Tosato G, Little RF. Therapy insight: AIDS-related malignancies–the influence of antiviral therapy on pathogenesis and management. Nat Clin Pract Oncol. 2005;2:406–15.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this entry
Cite this entry
Tosato, G. (2018). Primary Effusion Lymphoma. In: Hope, T.J., Richman, D.D., Stevenson, M. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7101-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7101-5_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-7100-8
Online ISBN: 978-1-4939-7101-5
eBook Packages: MedicineReference Module Medicine